Last reviewed · How we verify
NCT06283329
Residual Vocal Cords Curarization Correlation Between Clinical and Ultrasound Endpoints
trial testing vocal cords echography in Residual Curarization in 70 participants. Completed in 31 December 2023.
31 December 2023
Quick facts
| Lead sponsor | General Administration of Military Health, Tunisia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 1 December 2023 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Tunisia |
Drugs / interventions tested
- vocal cords echography
Conditions studied
- Residual Curarization — all drugs for Residual Curarization →
Sponsor
General Administration of Military Health, Tunisia — full company profile →
Who can join
Adults 18 to 70, any sex, with Residual Curarization. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Through recent studies residual curarization (RC) remains frequent but serious event, that could be easily avoided in the presence of a paraclinical monitoring and by antagonization of curares. However, conventional monitors focus only on peripheral muscles, whereas ultrasonography allows direct visualization of laryngeal muscles, particularly the vocal cords, which are directly influenced by neuromuscular blocking agents. The aim of the study was to evaluate the ultrasound mobility of the vocal cords after awakening and extubation of general anesthesia compared to their preoperative mobility and its correlation with clinical and paraclinical diagnostic criteria (DG) for RC.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06283329
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other General Administration of Military Health, Tunisia trials
Trials by the same sponsor.
- NCT05993312 — Quality of Life in Traumatic Brain Injury Patients · unknown
- NCT06021912 — e-ITAG Allergen Immunotherapy in the Management of Allergic Asthma · unknown
- NCT05516173 — Role of Depression in Blood Pressure Control. Study · unknown
- NCT05311111 — Efficacy and Safety of the Distal Radial Approach · NA · unknown
- NCT05822180 — Evaluation of the Efficacy and Safety of Nano-S1 · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06283329 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by General Administration of Military Health, Tunisia
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06283329.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing